# Short-term Effects of Intravitreal Bevacizumab and Triamcinolone in Patients With Diabetic Macular Edema

> **NCT00563940** · — · COMPLETED · sponsor: **Insel Gruppe AG, University Hospital Bern** · enrollment: 30 (actual)

## Conditions studied

- Diabetic Macular Edema

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT00563940
- **Lead sponsor:** Insel Gruppe AG, University Hospital Bern
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2007-03
- **Primary completion:** 2010-02
- **Final completion:** 2010-02
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2019-07-08

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00563940

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00563940, "Short-term Effects of Intravitreal Bevacizumab and Triamcinolone in Patients With Diabetic Macular Edema". Retrieved via AI Analytics 2026-06-14 from https://api.ai-analytics.org/clinical/NCT00563940. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*